Literature DB >> 32998878

Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning.

Jie-Yi Shi1, Xiaodong Wang2, Guang-Yu Ding1, Zhou Dong3, Jing Han4, Zehui Guan3, Li-Jie Ma5, Yuxuan Zheng2, Lei Zhang2, Guan-Zhen Yu6, Xiao-Ying Wang1, Zhen-Bin Ding1, Ai-Wu Ke1, Haoqing Yang2, Liming Wang2, Lirong Ai3, Ya Cao7, Jian Zhou1,8, Jia Fan1,8, Xiyang Liu9, Qiang Gao10,8,11.   

Abstract

OBJECTIVE: Tumour pathology contains rich information, including tissue structure and cell morphology, that reflects disease progression and patient survival. However, phenotypic information is subtle and complex, making the discovery of prognostic indicators from pathological images challenging.
DESIGN: An interpretable, weakly supervised deep learning framework incorporating prior knowledge was proposed to analyse hepatocellular carcinoma (HCC) and explore new prognostic phenotypes on pathological whole-slide images (WSIs) from the Zhongshan cohort of 1125 HCC patients (2451 WSIs) and TCGA cohort of 320 HCC patients (320 WSIs). A 'tumour risk score (TRS)' was established to evaluate patient outcomes, and then risk activation mapping (RAM) was applied to visualise the pathological phenotypes of TRS. The multi-omics data of The Cancer Genome Atlas(TCGA) HCC were used to assess the potential pathogenesis underlying TRS.
RESULTS: Survival analysis revealed that TRS was an independent prognosticator in both the Zhongshan cohort (p<0.0001) and TCGA cohort (p=0.0003). The predictive ability of TRS was superior to and independent of clinical staging systems, and TRS could evenly stratify patients into up to five groups with significantly different prognoses. Notably, sinusoidal capillarisation, prominent nucleoli and karyotheca, the nucleus/cytoplasm ratio and infiltrating inflammatory cells were identified as the main underlying features of TRS. The multi-omics data of TCGA HCC hint at the relevance of TRS to tumour immune infiltration and genetic alterations such as the FAT3 and RYR2 mutations.
CONCLUSION: Our deep learning framework is an effective and labour-saving method for decoding pathological images, providing a valuable means for HCC risk stratification and precise patient treatment. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer; liver

Mesh:

Year:  2020        PMID: 32998878     DOI: 10.1136/gutjnl-2020-320930

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Machine Learning-Based Risk Model for Predicting Early Mortality After Surgery for Infective Endocarditis.

Authors:  Li Luo; Sui-Qing Huang; Chuang Liu; Quan Liu; Shuohui Dong; Yuan Yue; Kai-Zheng Liu; Lin Huang; Shun-Jun Wang; Hua-Yang Li; Shaoyi Zheng; Zhong-Kai Wu
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

Review 2.  Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence.

Authors:  Ying Xu; Guan-Hua Su; Ding Ma; Yi Xiao; Zhi-Ming Shao; Yi-Zhou Jiang
Journal:  Signal Transduct Target Ther       Date:  2021-08-20

3.  Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography videos.

Authors:  Lu Zhang; Yicheng Jiang; Zhe Jin; Wenting Jiang; Bin Zhang; Changmiao Wang; Lingeng Wu; Luyan Chen; Qiuying Chen; Shuyi Liu; Jingjing You; Xiaokai Mo; Jing Liu; Zhiyuan Xiong; Tao Huang; Liyang Yang; Xiang Wan; Ge Wen; Xiao Guang Han; Weijun Fan; Shuixing Zhang
Journal:  Cancer Imaging       Date:  2022-05-12       Impact factor: 5.605

4.  Predicting gastric cancer outcome from resected lymph node histopathology images using deep learning.

Authors:  Xiaodong Wang; Ying Chen; Yunshu Gao; Huiqing Zhang; Zehui Guan; Zhou Dong; Yuxuan Zheng; Jiarui Jiang; Haoqing Yang; Liming Wang; Xianming Huang; Lirong Ai; Wenlong Yu; Hongwei Li; Changsheng Dong; Zhou Zhou; Xiyang Liu; Guanzhen Yu
Journal:  Nat Commun       Date:  2021-03-12       Impact factor: 14.919

Review 5.  Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine.

Authors:  Nurbubu T Moldogazieva; Innokenty M Mokhosoev; Sergey P Zavadskiy; Alexander A Terentiev
Journal:  Biomedicines       Date:  2021-02-06

Review 6.  Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk.

Authors:  Naoto Kubota; Naoto Fujiwara; Yujin Hoshida
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

Review 7.  Deep learning in hepatocellular carcinoma: Current status and future perspectives.

Authors:  Joseph C Ahn; Touseef Ahmad Qureshi; Amit G Singal; Debiao Li; Ju-Dong Yang
Journal:  World J Hepatol       Date:  2021-12-27

8.  Multi-task deep learning network to predict future macrovascular invasion in hepatocellular carcinoma.

Authors:  Sirui Fu; Haoran Lai; Meiyan Huang; Qiyang Li; Yao Liu; Jiawei Zhang; Jianwen Huang; Xiumei Chen; Chongyang Duan; Xiaoqun Li; Tao Wang; Xiaofeng He; Jianfeng Yan; Ligong Lu
Journal:  EClinicalMedicine       Date:  2021-12-09

Review 9.  Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction.

Authors:  David Nam; Julius Chapiro; Valerie Paradis; Tobias Paul Seraphin; Jakob Nikolas Kather
Journal:  JHEP Rep       Date:  2022-02-02

Review 10.  Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential.

Authors:  Xingping Zhang; Yanchun Zhang; Guijuan Zhang; Xingting Qiu; Wenjun Tan; Xiaoxia Yin; Liefa Liao
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.